Table 2.
Measurements before and after administration of açai pulp
| Measurement | Time | Mean | Std. Deviation | Sig. |
|---|---|---|---|---|
| Fasting Glucose (mg/dl) | Baseline | 98.0 | 10.1 | .018 |
| Day 30 | 92.8 | 10.9 | ||
| Insulin (μU/ml) | Baseline | 8.92 | 5.4 | .017 |
| Day 30 | 6.68 | 3.3 | ||
| Serum Cholesterol (mg/dl) | Baseline | 159.2 | 37.4 | .030 |
| Day 30 | 141.8 | 28.3 | ||
| Cholesterol Ratio | Baseline | 3.79 | 1.0 | .051 |
| Day 30 | 3.42 | 0.9 | ||
| VLDL (mg/dl) | Baseline | 26.2 | 13.5 | .111 |
| Day 30 | 20.9 | 8.3 | ||
| LDL (mg/dl) | Baseline | 90.1 | 29.1 | .051 |
| Day 30 | 78.1 | 25.3 | ||
| HDL (mg/dl) | Baseline | 42.9 | 8.4 | .953 |
| Day 30 | 42.8 | 9.3 | ||
| Triglycerides (mg/dl) | Baseline | 130.8 | 67.3 | .116 |
| Day 30 | 104.2 | 41.6 | ||
Measurements of glucose, insulin and lipid levels before and after administration of Sambazon açai for 30 days (given as means and standard deviations) were compared using paired t-tests to determine the significance of the change from baseline.